LONDON--(BUSINESS WIRE)--Jan. 24, 2018--
LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a
market-leading medical technology company, will host a conference call
to discuss its fourth quarter and full-year 2017 results on Wednesday,
Feb. 28, 2018 at 8 a.m. CST (2 p.m. GMT).
The Company will release its fourth quarter and full-year 2017 results
earlier that morning, before the open of the U.S. financial markets.
A live webcast of the conference call will be available on the Investor
Relations section of LivaNova’s website at www.livanova.com.
To listen to the conference call by telephone, dial 866-393-4306 (if
dialing from within the U.S.) or 734-385-2616 (if dialing from outside
the U.S.). The conference ID is 2898787. Listeners should log on
approximately 10 minutes in advance to ensure proper setup to receive
the webcast. A replay will be available on the LivaNova website for 90
days following the call.
LivaNova PLC is a global medical technology company built on nearly five
decades of experience and a relentless commitment to improve the lives
of patients around the world. LivaNova’s advanced technologies and
breakthrough treatments provide meaningful solutions for the benefit of
patients, healthcare professionals and healthcare systems. Headquartered
in London and with a presence in more than 100 countries worldwide, the
company employs more than 4,500 employees. LivaNova operates as three
business franchises: Cardiac Surgery, Neuromodulation and Cardiac Rhythm
Management, with operating headquarters in Mirandola (Italy),
Houston (U.S.A.) and Clamart (France), respectively.
For more information, please visit www.livanova.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180124005442/en/
Source: LivaNova PLC
LivaNova PLC Investor Relations and Media
Karen King, +1-281-228-7262
President, Investor Relations & Corporate Communications
Corporate External Communications Manager